{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:30:33Z","timestamp":1792452633055,"version":"4.5.0"},"reference-count":40,"publisher":"Oxford University Press (OUP)","issue":"15","license":[{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Inflammatory bowel disease (IBD) is associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD). We compared cardiovascular disease (CVD) risk factors and 10-year risk in IBD patients to the general population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>In this cross-sectional study, consecutive IBD patients \u226545 years were included. History of ASCVD and CVD risk factors (smoking, hypertension, overweight, hypercholesterolaemia, diabetes, and metabolic syndrome) were assessed. The Systematic COronary Risk Evaluation (SCORE2) algorithm was used to estimate 10-year CVD risk. One to four age\/sex-matched controls were derived from the prospective population-based Rotterdam Study cohort. In total, 235 IBD patients were included {56% women, median age 59 years [interquartile range (IQR) 51\u201366]} and matched to 829 controls [56% women, median age 61 years (IQR 56\u201367)]. Inflammatory bowel disease patients experienced ASCVD events more often compared with matched controls [odds ratio (OR) 2.01, 95% confidence interval (CI) 1.23\u20133.27], specifically heart failure (OR 2.02, 95% CI 1.02\u20134.01) and coronary heart disease (OR 2.01, 95% CI 1.7\u20133.13). Inflammatory bowel disease patients showed lower odds of overweight (OR 0.48, 95% CI 0.35\u20130.66) and hypercholesterolaemia (OR 0.45, 95% CI 0.31\u20130.65) and higher odds of hypertension (OR 1.67, 95% CI 1.19\u20132.32), as well as higher waist circumference (+4 cm, P = 0.006) and triglyceride levels (+0.6 mmol\/L, P &amp;lt; 0.001) as compared with controls. Mean 10-year CVD risk was 4.0% [standard deviation (SD) \u00b12.6] in 135 IBD patients vs. 6.0% (SD \u00b11.6) in 506 controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The increased CVD risk in IBD is discrepant with the 10-year CVD risk estimate. Systematic COronary Risk Evaluation may underestimate CVD risk in IBD patients due to differing CVD risk profiles compared with the general population, including a lower prevalence of hypercholesterolaemia and overweight and a higher prevalence of hypertension, abdominal obesity, and hypertriglyceridaemia.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwad124","type":"journal-article","created":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T15:07:37Z","timestamp":1681916857000},"page":"1615-1622","source":"Crossref","is-referenced-by-count":35,"title":["Cardiovascular risk profiles in patients with inflammatory bowel disease differ from matched controls from the general population"],"prefix":"10.1093","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8874-8766","authenticated-orcid":false,"given":"Jasmijn A M","family":"Sleutjes","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam , Dr. Molewaterplein 40 Na-6, 3015 GD, PO Box 2040, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Janneke","family":"van der Woude","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam , Dr. Molewaterplein 40 Na-6, 3015 GD, PO Box 2040, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P J Pepijn","family":"Verploegh","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam , Dr. Molewaterplein 40 Na-6, 3015 GD, PO Box 2040, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2736-7542","authenticated-orcid":false,"given":"Elif","family":"Aribas","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5976-6519","authenticated-orcid":false,"given":"Maryam","family":"Kavousi","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6870-9962","authenticated-orcid":false,"given":"Jeanine E","family":"Roeters van Lennep","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam , Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie C","family":"de Vries","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center Rotterdam , Dr. Molewaterplein 40 Na-6, 3015 GD, PO Box 2040, Rotterdam , The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,4,19]]},"reference":[{"key":"2023102604192321400_zwad124-B1","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1177\/2047487318792952","article-title":"Inflammatory bowel disease and cardiovascular disease incidence and mortality: a meta-analysis","volume":"25","author":"Sun","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2023102604192321400_zwad124-B2","first-page":"389","article-title":"Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities","volume":"16","author":"B\u00e4ck","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2023102604192321400_zwad124-B3","doi-asserted-by":"crossref","DOI":"10.1177\/17562848211032126","article-title":"Thromboembolic and atherosclerotic cardiovascular events in inflammatory bowel disease: epidemiology, pathogenesis and clinical management","volume":"14","author":"Sleutjes","year":"2021","journal-title":"Therap Adv Gastroenterol"},{"key":"2023102604192321400_zwad124-B4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/ecco-jcc\/jjv213","article-title":"The first European evidence-based consensus on extra-intestinal manifestations in inflammatory bowel disease","volume":"10","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2023102604192321400_zwad124-B5","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2023102604192321400_zwad124-B6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/ajg.2011.63","article-title":"Inflammatory bowel disease is associated with an increased incidence of cardiovascular events","volume":"106","author":"Yarur","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2023102604192321400_zwad124-B7","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1097\/MIB.0000000000000109","article-title":"Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease","volume":"20","author":"Aggarwal","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"2023102604192321400_zwad124-B8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/ecco-jcc\/jjy164","article-title":"Cardiovascular risk profile among patients with inflammatory bowel disease: a population-based study of more than 100 000 individuals","volume":"13","author":"Aarestrup","year":"2019","journal-title":"J Crohns Colitis"},{"key":"2023102604192321400_zwad124-B9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/CEG.S243478","article-title":"Cardiovascular risk in individuals with inflammatory bowel disease","volume":"13","author":"Biondi","year":"2020","journal-title":"Clin Exp Gastroenterol"},{"key":"2023102604192321400_zwad124-B10","doi-asserted-by":"crossref","first-page":"100171","DOI":"10.1016\/j.ajpc.2021.100171","article-title":"Prevalence of cardiovascular risk factors in a nationally representative adult population with inflammatory bowel disease without atherosclerotic cardiovascular disease","volume":"6","author":"Agrawal","year":"2021","journal-title":"Am J Prev Cardiol"},{"key":"2023102604192321400_zwad124-B11","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1093\/eurjpc\/zwac110","article-title":"Prevalence of ideal cardiovascular health and its correlates in patients with inflammatory bowel disease, psoriasis and spondyloarthropathy","volume":"29","author":"Sleutjes","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2023102604192321400_zwad124-B12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10654-020-00640-5","article-title":"Objectives, design and main findings until 2020 from the Rotterdam Study","volume":"35","author":"Ikram","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"2023102604192321400_zwad124-B13","first-page":"3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume-title":"Circulation","author":"National Cholesterol Education Program Expert Panel on Detection, E. and A. Treatment of High Blood Cholesterol","year":"2002"},{"key":"2023102604192321400_zwad124-B14","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","author":"Group, S.W. and E.S.C.C.R. Collaboration","year":"2021","journal-title":"Eur Heart J"},{"key":"2023102604192321400_zwad124-B15","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","article-title":"SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions","volume":"42","author":"Group, S.O.W. and E.S.C.C.R. Collaboration","year":"2021","journal-title":"Eur Heart J"},{"key":"2023102604192321400_zwad124-B16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.0006-341X.2000.00118.x","article-title":"Substantial gains in bias reduction from matching with a variable number of controls","volume":"56","author":"Ming","year":"2000","journal-title":"Biometrics"},{"key":"2023102604192321400_zwad124-B17","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"key":"2023102604192321400_zwad124-B18","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1210\/jc.2010-2061","article-title":"Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones","volume":"96","author":"Wang","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2023102604192321400_zwad124-B19","first-page":"181","article-title":"An overview of lipid abnormalities in patients with inflammatory bowel disease","volume":"24","author":"Agouridis","year":"2011","journal-title":"Ann Gastroenterol"},{"key":"2023102604192321400_zwad124-B20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.4103\/1319-3767.87177","article-title":"Metabolic syndrome frequency in inflammatory bowel diseases","volume":"17","author":"Yorulmaz","year":"2011","journal-title":"Saudi J Gastroenterol"},{"key":"2023102604192321400_zwad124-B21","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00535-010-0247-z","article-title":"Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population","volume":"45","author":"Nagahori","year":"2010","journal-title":"J Gastroenterol"},{"key":"2023102604192321400_zwad124-B22","doi-asserted-by":"crossref","first-page":"S538","DOI":"10.1093\/ecco-jcc\/jjx180.961","article-title":"P834 metabolic syndrome occurrence in patients with inflammatory bowel disease in Poland\u2014preliminary results from the POLIBD study","volume":"12","author":"Sztembis","year":"2018","journal-title":"J Crohns Colitis"},{"key":"2023102604192321400_zwad124-B23","doi-asserted-by":"crossref","first-page":"704145","DOI":"10.3389\/fcvm.2021.704145","article-title":"Impact of metabolic syndrome and it's components on prognosis in patients with cardiovascular diseases: a meta-analysis","volume":"8","author":"Li","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2023102604192321400_zwad124-B24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jdi.12075","article-title":"Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness","volume":"4","author":"Shin","year":"2013","journal-title":"J Diabetes Investig"},{"key":"2023102604192321400_zwad124-B25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1080\/16583655.2021.2009680","article-title":"Association of metabolic syndrome components with alterations in oxidative stress and cytokines expression","volume":"15","author":"Abdelazeem","year":"2021","journal-title":"J Taibah Univ Sci"},{"key":"2023102604192321400_zwad124-B26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/joim.12584","article-title":"Roles of the gut in the metabolic syndrome: an overview","volume":"281","author":"F\u00e4ndriks","year":"2017","journal-title":"J Intern Med"},{"key":"2023102604192321400_zwad124-B27","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2147\/TCRM.S140618","article-title":"Are adipocytokines inflammatory or metabolic mediators in patients with inflammatory bowel disease?","volume":"13","author":"Kahraman","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"2023102604192321400_zwad124-B28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01.MIB.0000195975.97673.f5","article-title":"Increased insulin resistance and beta cell activity in patients with Crohn's disease","volume":"12","author":"Bregenzer","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"2023102604192321400_zwad124-B29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1365-2036.1999.00461.x","article-title":"Glucose metabolism and insulin sensitivity in inactive inflammatory bowel disease","volume":"13","author":"Capristo","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"2023102604192321400_zwad124-B30","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3389\/fimmu.2014.00462","article-title":"Adipose-tissue and intestinal inflammation\u2014visceral obesity and creeping fat","volume":"5","author":"Kredel","year":"2014","journal-title":"Front Immunol"},{"key":"2023102604192321400_zwad124-B31","doi-asserted-by":"crossref","first-page":"e0201991","DOI":"10.1371\/journal.pone.0201991","article-title":"Clinical activity is an independent risk factor of ischemic heart and cerebrovascular arterial disease in patients with inflammatory bowel disease","volume":"13","author":"Le Gall","year":"2018","journal-title":"PLoS One"},{"key":"2023102604192321400_zwad124-B32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-145-1-200607040-00128","article-title":"The effect of including C-reactive protein in cardiovascular risk prediction models for women","volume":"145","author":"Cook","year":"2006","journal-title":"Ann Intern Med"},{"key":"2023102604192321400_zwad124-B33","doi-asserted-by":"crossref","first-page":"e56944","DOI":"10.1371\/journal.pone.0056944","article-title":"Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death\u2013a Danish nationwide cohort study","volume":"8","author":"Kristensen","year":"2013","journal-title":"PLoS One"},{"key":"2023102604192321400_zwad124-B34","doi-asserted-by":"crossref","first-page":"e23964","DOI":"10.1002\/jcla.23964","article-title":"Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis","volume":"35","author":"Wu","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"2023102604192321400_zwad124-B35","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13075-023-03018-6","article-title":"The association between systemic immune-inflammation index and rheumatoid arthritis: evidence from NHANES 1999\u20132018","volume":"25","author":"Liu","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"2023102604192321400_zwad124-B36","first-page":"352","article-title":"Systemic immune-inflammation index (SII) predicts increased severity in psoriasis and psoriatic arthritis","volume":"46","author":"Yorulmaz","year":"2020","journal-title":"Curr Health Sci J"},{"key":"2023102604192321400_zwad124-B37","doi-asserted-by":"crossref","first-page":"e1003432","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study","volume":"17","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med"},{"key":"2023102604192321400_zwad124-B38","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/gutjnl-2019-318932","article-title":"Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study","volume":"69","author":"Kirchgesner","year":"2020","journal-title":"Gut"},{"key":"2023102604192321400_zwad124-B39","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/gutjnl-2017-314015","article-title":"Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study","volume":"67","author":"Kirchgesner","year":"2018","journal-title":"Gut"},{"key":"2023102604192321400_zwad124-B40","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S2468-1253(22)00021-8","article-title":"Lifestyle, behaviour, and environmental modification for the management of patients with inflammatory bowel diseases: an International Organization for Study of Inflammatory Bowel Diseases consensus","volume":"7","author":"Ananthakrishnan","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwad124\/50205695\/zwad124.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/30\/15\/1615\/52305802\/zwad124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/30\/15\/1615\/52305802\/zwad124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:47:55Z","timestamp":1698281275000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/30\/15\/1615\/7131289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,19]]},"references-count":40,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,4,19]]},"published-print":{"date-parts":[[2023,10,26]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwad124","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10]]},"published":{"date-parts":[[2023,4,19]]}}}